Customer Stories and Client Testimonials

Page: [1]  2   3   4   >  [All News]

Advanced Analytical Technologies, Inc. Instrument Empowers Discovery at the Delaware Biotechnology Institute

Published: Monday, July 14th, 2014
Tags: Corporate News, Customer Stories, Fragment Analyzer

A leader in next generation sequencing applications – the Delaware Biotechnology Institute's (DBI) DNA Sequencing & Genotyping Center -- implements the Fragment AnalyzerTM capillary electrophoresis instrument to allow researchers to accelerate their discoveries. Advanced Analytical Technologies, Inc. (AATI), an Ames, Iowa-based analytical instrumentation company, makes the Fragment AnalyzerTM.

Read More...

Advanced Analytical Technologies, Inc. CE Instrument Enables Research at Academia Sinica

Published: Wednesday, July 2nd, 2014
Tags: Corporate News, Customer Stories, Fragment Analyzer

The Academia Sinica in Taipei, Taiwan, a leader in Next Generation Sequencing, is implementing the use of the Fragment AnalyzerTM as part of their research services efforts. Advanced Analytical Technologies, Inc. (AATI), an Ames, Iowa-based analytical instrumentation company, makes the Fragment Analyzer.

Read More...

European Molecular Biology Laboratory

Published: Wednesday, January 1st, 2014
Tags: Corporate News, Customer Stories, Fragment Analyzer

There is no sign that interest in massively parallel sequencing (MPS) will fade away anytime soon. Exactly the contrary is happening: application of this technique is spreading into more and more areas of basic as well as applied research. It is getting increasingly popular among researchers investigating genomes, transcriptomes, methylomes and other nucleic acid derived –omes of many different organisms, large and small. Also the capacity of sequencing instruments is on the rise. Thanks to the possibility of pooling many barcoded libraries in one ‘lane’ it is nowadays feasible to sequence simultaneously large numbers of samples.

Read More...

Massachusetts General Hospital Deploys Fragment Analyzer Against Cancer

Published: Friday, December 20th, 2013
Tags: Customer Stories, Fragment Analyzer

The Massachusetts General Hospital Center for Integrated Diagnostics in Boston has been applying molecular pathology in the ongoing battle against cancer. Patients at MGH are routinely tested with advanced, specialized clinical assays to profile their tumors at the molecular level. Identification of cancer driver mutations would enable oncologists to customize treatments for their patients in a more personalized manner or to better define the patient’s disease with respect to diagnosis and/or prognosis.

Read More...
Page: [1]  2   3   4   >  [All News]

Upcoming Events

TIDES 2017

04/30/2017 - 05/03/2017
- San Diego, CA

PACBIO SMRT Leiden

05/02/2017 - 05/04/2017
- Leiden, Netherlands

Illumina User Group Meeting - Mid Atlantic

05/04/2017
- Bethesda, MD

View All Events